- CNBC•yesterday
Suze Orman says this is how much money you should have in your emergency fund
If you're trying to get your financial house in order, any number of experts will tell you the same thing: Build up an emergency fund of at least three to six months' worth of living expenses. "They're idiots," Orman said at the 2017 eMerge Americas conference, answering a question about how much to keep in your emergency fund. A million potential scenarios could drain your savings without warning, so it's better to have at least eight to 12 months' worth of living expenses squirreled away.
Business Insider•14 hours agoThe mysterious trader known as '50 Cent' appears to be back betting on more stock market chaos
The mysterious volatility trader known as "50 Cent" appears to have made some new bets this week that the stock market will see turbulence over the summer. The trades match a growing sentiment across Wall Street that the stock market could be in for a rocky ride over the next few months. Known for his consistent purchases of bite-size Cboe Volatility Index (VIX) options — usually costing about 50 cents — the trader has historically positioned himself to profit from market turbulence.
- Bloomberg•21 hours ago
Qualcomm's $43 Billion NXP Deal Approved by Chinese Regulators
Qualcomm Inc.’s $43 billion acquisition of NXP Semiconductors NV has been approved by Chinese regulators, according to people familiar with the matter who asked not to be identified. Clearance from China would remove the final regulatory hurdle for the purchase, which has been pending for more than 18 months. The decision by Chinese regulators will allow the transaction to be completed ahead of a July deadline set by NXP, which said it would abandon the deal if it wasn’t approved by then.
- CNBC Videos•7 hours ago
AT&T CEO: We’ll launch free mobile 'skinny' bundle next w...
Randall Stephenson, AT&T Chairman and CEO, speaks with CNBC's "Squawk Box" following the telecom giant's big court victory in its merger with Time Warner.
InvestorPlace•5 hours agoJust Stop Worrying Already and Buy Bank of America Corp Stock
Last year was a good great one for Bank of America Corp (NYSE:BAC) shareholders. BAC stock was up a little more than 40% in 2017, following 2016’s 60% advance. While the market’s up roughly 4% year-to-date thanks to the recent recovery, BAC stock is barely at a break-even, with shares of the mega-bank simply not riding the recent bullish wave.
InvestorPlace•5 hours agoOK, I’ll Say It. Advanced Micro Devices, Inc. Stock Is Beyond Overextended
AMD stock is up at least 30% for you, and if you stepped in at the early April low, you’re sitting on 66% gain. Advanced Micro Devices shares may look and feel red hot right now, but the rally’s carried AMD stock a little too far, too fast, and a pullback is nigh.
InvestorPlace•yesterdayShould You Buy These 3 Red-Hot Chinese Stocks?
Chinese stocks have been hot over the past few weeks, turning a lot of investors’ heads. While Alibaba Group Holding Ltd (NYSE:BABA) breaking to new highs and JD.Com Inc(ADR) (NASDAQ:JD) ripping higher from critical support have been promising, a new
- TheStreet.com•yesterday
Four Stocks Poised for Big Gains: Cramer's 'Off the Charts'
With a stock market that's been picking up steam for quite some time, finding reasonable places to invest is challenging. Moreno has several picks he feels are ready to move higher, starting with United States Steel Corp. The steelmaker's stock has been trading sideways despite President Trump's imposition of steel tariffs on imports.
- Zacks•7 hours ago
Zacks Value Investor Highlights: Gilead Sciences, Biogen, Celgene, Lannett and Valeant
June 15, 2018 – Zacks Value Investor is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Every week, Tracey Ryniec, the editor of Zacks Value Investor portfolio service, shares some of her top value investing tips and stock picks. Recently, investors on Stocktwits and Twitter have been asking about some of the drug stocks.
- TheStreet.com•20 hours ago
9 Stocks Goldman Sachs Thinks Will Blow Wall Street's Performance Away in 2019
2018 is just about over, in the minds of some investors. "We expect investors will soon look past 2018 and focus on 2019 growth," says Goldman Sachs strategist David Kostin. "For many years, beginning in July investors would start to value stocks
- TheStreet.com•4 hours ago
3 Fierce Chinese Tech Stocks to Trade Right Now
Don't be scared to trade China. As the trade war volatility escalates between the U.S. and China, Trump has added more fuel to fire with his latest offensive to 'restrict control exports of industrially significant technology'. Chinese e-commerce powerhouse Alibaba has eclipsed the headlines for all the right reasons.
- TheStreet.com•35 minutes ago
Dow Falls as U.S. Imposes Tariffs on $50 Billion of Chinese Goods
The U.S. imposed tariffs on about $50 billion in imports from China, which has pledged to retaliate. closed the $85.4 billion purchase Time Warner Inc. Stocks tumbled on Friday, June 15, after the U.S. imposed tariffs on about $50 billion in imports from China.
- Bloomberg•yesterday
Royal Caribbean Has a $240,000 Cruise for You
If you have a quarter of a million dollars to spare, Royal Caribbean Cruises Ltd. will soon have a vacation for you. The Miami-based cruise operator agreed to buy a 66.7 percent stake in closely held Silversea Cruises Ltd. based on an enterprise value of about $2 billion. The deal will give the company new luxury offerings, including a stay in the Owner’s Suite that starts at $240,000 per person for Silversea’s World Cruise 2020, a 140-day trip around the globe.
- TheStreet.com•6 hours ago
GE's Stock Having a Brutal June
Shares of General Electric are having a rough month as investors stay worried about the industrial giant's health. Meanwhile, Trump's new tariffs on China have the market on edge.
- CNBC Videos•22 hours ago
These are the surging tech stocks to buy right now, techn...
3 tech stocks to buy at highs. With Todd Gordon, TradingAnalysis.com, CNBC's Melissa Lee and the Fast Money traders, Tim Seymour, David Seaburg, Brian Kelly and Guy Adami.
- InvestorPlace•6 hours ago
Teva Pharmaceutical Industries Limited Stock Still Is a Deep Value Play
The U.S. government is shifting its focus from accusing drug companies of overcharging to encouraging the marketplace to operate more competitively. On May 31, FDA Commissioner Scott Gottlieb, announced a draft guidance that will limit drug companies in delaying generics to market. Previously, generics needed to negotiate with branded firms.
- FX Empire•10 hours ago
Trump May Have Built Enough Goodwill to Press Forward with Tariffs Against China
Investors appear to be bracing for a “risk-off” session amid chatter that U.S. President Donald Trump will press ahead with additional tariffs on Chinese products. According to a report from Reuters, President Trump is expected to announce today “pretty significant action” in tariffs on Chinese goods worth around $50 billion. Some are saying that Trump is leveraging his denuclearization deal earlier in the week with North Korea against China, perhaps feeling he doesn’t need them to negotiate with the rogue nation.
- Barrons.com•5 hours ago
Big Biotech Set for Earnings Blowout?
Earlier this year, Oppenheimer's Hartaj Singh argued that earnings expectations were too high for big biotech companies heading into the first-quarter reporting season. Ahead of the reports, due out in mid-July, Singh argues that fundamentals for large-cap biotech, as well as sector sentiment are "slowly but surely improving," leading him to believe that the stocks could outperform, led by Gilead Sciences (GILD), Alexion Pharmaceuticals (ALXN), and Vertex Pharmaceuticals (VRTX). For Gilead, he's upbeat about a more stable pricing environment for hepatitis C treatments, while investors are getting more interested in the company's "budding" immunology and nonalcoholic steatohepatitis (NASH) franchises, setting up an attractive risk-reward profile going into the second quarter. Alexion reported "stellar" first-quarter earnings, and Singh sees another strong quarter ahead, and he wonders "when the Street will start giving management credit for relentless execution." Vertex is one of his favorite large-cap biotechs, and he sees a good report ahead, along with an update about the progress of its cystic-fibrosis drugs.
- TheStreet.com•yesterday
Warren Buffett at Age 87 Still Does One Amazing Thing That Drives Success
Known as the 'Oracle of Omaha', Buffett has made himself into a household name through legendary investing techniques that have amassed him a $79 billion net worth at 87 years old. Buffett started playing the markets at the young age of 11, but he's offered sage wisdom on investing for years since he made his first millions.
- InvestorPlace•yesterday
Target Pulls ‘Baby Daddy’ Cards for Father’s Day Amid Backlash
Target Corporation (NYSE:TGT) is pulling a Father’s Day card after complaints from customers. Source: Mike Mozart via Flickr (Modified) The card that was being sold at Target locations includes the words “Baby Daddy” in big text on the front of
- InvestorPlace•9 hours ago
3 Potential Takeover Targets
Takeovers can occur for several reasons. Sometimes a successful, larger company, in order to become even more dominant, wants to acquire superior technology or a popular product developed by a smaller rival. Other times a struggling, larger company, to
- Zacks•22 hours ago
Growth & Income Buys | Johnson & Johnson and International Paper
This week’s video covers two companies where management has made key decisions for the future of their respective companies; Johnson & Johnson (JNJ), and International Paper (IP).Johnson & Johnson JNJ has the largest market capitalization for any U.S.
- InvestorPlace•yesterday
The Odds of Sprint Corp’s T-Mobile Merger Just Went Through the Roof
The biggest news in the stock market recently is perhaps that a federal judge approved the proposed $85 billion acquisition of media giant Time Warner Inc (NYSE:TWX) by telecom giant AT&T Inc. (NYSE:T). From this perspective, the merger is particularly good news for Sprint Corp (NYSE:S) shareholders. Sprint stock has been on a roller coaster ride over the past several months ever since its proposed merger with T-Mobile Us Inc (NASDAQ:TMUS).
- Zacks•9 hours ago
Evaluating Netflix (NFLX) Stock At New All-Time High
Netflix NFLX stock climbed 3.41% on Thursday to close right around its brand new all-time high a day after Goldman Sachs GS analysts announced their extremely bullish outlook for the streaming video power. Now let’s see why the investment banking giant is so positive and take a look at some of Netflix’s current fundamentals to help investors see if they agree. Goldman analysts reiterated the firm’s buy rating for NFLX on Wednesday and also upped their price target from $390 per share to $490 per share.
- InvestorPlace•3 hours ago
The Issue That Will Bring Twitter Inc Back to Earth
Micro-blogging social media company Twitter Inc (NYSE:TWTR) has seen an impressive rally over the past year. TWTR stock rose to $45 per share in a matter of months after investors started to see some potential from the little blue bird when it finally returned to profitability during the final quarter of 2017. While some are calling for TWTR to make its way above $50, I’m not so optimistic.
